Adagio Medical Holdings (ADGM) Total Debt (2023 - 2024)

Adagio Medical Holdings (ADGM) reported Total Debt of $16.1 million for Q4 2024, up 774.65% on a YoY basis from $1.8 million in Q1 2024, and up 16.92% sequentially from $13.8 million in Q3 2024.

Adagio Medical Holdings (ADGM) Total Debt (2023 - 2024) Analysis & Trends

Adagio Medical Holdings (ADGM) has 2 years of Total Debt data on file, last reported at $16.1 million in Q4 2024.

  • For the quarter ending Q4 2024, Total Debt rose 774.65% year-over-year to $16.1 million; the trailing twelve-month figure through Dec 2024 stood at $16.1 million (up 774.65% YoY), and the FY2024 full-year result was $16.1 million, up 774.65% from the prior year.
  • Total Debt grew to $16.1 million in Q4 2024, from $13.8 million in the prior quarter.
  • In the past five years, Total Debt ranged from a high of $16.1 million in Q4 2024 to a low of $1.8 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Abbott Laboratories 182.32 Bn 175.03 Bn 6.27 Bn 34.05 Bn
2 Stryker 128.82 Bn 125.95 Bn 3.81 Bn 14.72 Bn
3 Medtronic 108.46 Bn 99.24 Bn 6.41 Bn 27.96 Bn
4 Boston Scientific 68.25 Bn 66.79 Bn 3.61 Bn 11.03 Bn
5 Edwards Lifesciences 47.64 Bn 43.97 Bn 1.29 Bn 598.50 Mn
6 Dexcom 28.55 Bn 27.43 Bn 750.30 Mn -
7 GE HealthCare Technologies 28.51 Bn 26.22 Bn 1.98 Bn 10.14 Bn
8 Smith & Nephew 26.96 Bn 26.39 Bn - 3.18 Bn
9 Koninklijke Philips 25.42 Bn 22.29 Bn 2.07 Bn 9.48 Bn
10 Adagio Medical Holdings 22.33 Mn 22.33 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 16.08 Mn
Sep 30, 2024 13.75 Mn
Dec 31, 2023 1.84 Mn